Crossmark

High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro

Crossref DOI link: https://doi.org/10.1007/s11626-016-0117-y

Published Online: 2017-01-26

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yano, Shuya

Takehara, Kiyoto

Kishimoto, Hiroyuki

Tazawa, Hiroshi

Urata, Yasuo

Kagawa, Shunsuke

Bouvet, Michael

Fujiwara, Toshiyoshi

Hoffman, Robert M.
Funding

Funding for this research was provided by:

National Cancer Institute (US) (CA132971)

National Cancer Institute (US) (CA142669)

Ministry of Health, Labour and Welfare (10103827, 14525167)

Ministry of Health, Labour and Welfare (JP) (13801426)

Ministry of Education, Culture, Sports, Science and Technology, Japan (25293283)
License Information

License valid from 2017-01-26